Terry Reisine

Title: The Innovations of Terry Reisine

Introduction

Terry Reisine is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of opioid receptor research. With a total of 3 patents, her work focuses on the development of methods and compositions related to opioid receptors.

Latest Patents

One of her latest patents is titled "Methods of identifying agonists and antagonists of opioid receptors." This invention relates to compositions and methods for obtaining opioid receptor polypeptides. It also includes polynucleotides encoding these polypeptides, recombinant vectors carrying those sequences, and recombinant host cells. The invention discloses the cloning and functional expression of at least three different opioid receptor polypeptides. Additionally, it includes methods for using the isolated, recombinant receptor polypeptides in assays designed to select and improve substances capable of interacting with opioid receptor polypeptides for diagnostic, drug design, and therapeutic applications.

Another significant patent is "Nucleic acids encoding kappa opioid receptors." This invention also focuses on compositions and methods for obtaining opioid receptor polypeptides, specifically polynucleotides encoding kappa opioid receptor polypeptides. Similar to her previous patent, it involves recombinant vectors, host cells, and methods for using the isolated polypeptides in various applications.

Career Highlights

Terry Reisine is currently associated with Arch Development Corporation, where she continues her innovative work in the field of opioid receptors. Her research has contributed to advancements in understanding and developing treatments related to opioid receptors.

Collaborations

Throughout her career, Terry has collaborated with notable individuals such as Graeme I Bell and Kazuki Yasuda. These collaborations have further enhanced her research and contributions to the field.

Conclusion

Terry Reisine's work in opioid receptor research has led to significant innovations and advancements in the field. Her patents reflect her dedication to improving diagnostic and therapeutic applications related to opioid receptors.